Home » Topics » Regulatory

Regulatory
RSS

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

Study investigates Toprol-XL for reversal of cardiac remodeling

Sep. 4, 2001

GSK claims new adenosine A1 agonist formulations for the treatment of pain

Aug. 29, 2001

European approval granted for Ketek, Aventis' first-in-class antibiotic

Aug. 21, 2001

FDA approves Natrecor for treatment of congestive heart failure

Aug. 14, 2001

Roche receives first approval for PEGASYS

Aug. 10, 2001

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

Replagal receives European approval for Fabry's disease

Aug. 9, 2001

New intraocular pressure-lowering agent introduced to Japanese market

July 31, 2001

Genotropin approved in U.S. for growth failure in children born SGA

July 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.